These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 29144798

  • 1. PANCREAS METASTASES FROM PAPILLARY THYROID CARCINOMA: A REVIEW OF THE LITERATURE.
    Davidson M, Olsen RJ, Ewton AA, Robbins RJ.
    Endocr Pract; 2017 Dec; 23(12):1425-1429. PubMed ID: 29144798
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Case Report: A New Entity: Multiple Differentiated Variant of Papillary Thyroid Carcinoma With Advanced Clinical Behavior.
    Yang J, Gong R, Ma Y, Gao J, Li Z, Zhu J, Gong Y.
    Front Endocrinol (Lausanne); 2021 Dec; 12():654638. PubMed ID: 33897621
    [Abstract] [Full Text] [Related]

  • 4. Pancreatic metastasis from papillary thyroid carcinoma: Case report and literature review.
    Stein R, Harmon TS, Harmon CE, Kuo E, Ozdemir S.
    Hell J Nucl Med; 2021 Dec; 24(2):140-148. PubMed ID: 34352049
    [Abstract] [Full Text] [Related]

  • 5. Distant, solitary skeletal muscle metastasis in recurrent papillary thyroid carcinoma.
    Bae SY, Lee SK, Koo MY, Hur SM, Choi MY, Cho DH, Choe JH, Kim JH, Kim JS.
    Thyroid; 2011 Sep; 21(9):1027-31. PubMed ID: 21834676
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. SIMULTANEOUS METASTASES OF PAPILLARY THYROID CARCINOMA AND NEUROENDOCRINE TUMOR OF THE CECUM TO CERVICAL LYMPH NODES: A CASE REPORT.
    Romić M, Blažeković I, Mateša N, Franceschi M, Šiško-Markoš I, Kusić Z, Fröbe A, Jukić T.
    Acta Clin Croat; 2023 Apr; 62(1):230-233. PubMed ID: 38304356
    [Abstract] [Full Text] [Related]

  • 9. Pancreatic metastasis of papillary thyroid carcinoma preoperatively diagnosed by endoscopic ultrasound-guided fine-needle aspiration biopsy: a case report with review of literatures.
    Murakami Y, Shimura T, Okada R, Kofunato Y, Ishigame T, Yashima R, Nakano K, Suzuki S, Takenoshita S.
    Clin J Gastroenterol; 2018 Dec; 11(6):521-529. PubMed ID: 29948817
    [Abstract] [Full Text] [Related]

  • 10. PROGNOSTIC VALUE OF LYMPH NODE UPTAKE ON PRETREATMENT F-18 FDG PET/CT IN PATIENTS WITH N1B PAPILLARY THYROID CARCINOMA.
    Lee CH, Lee SW, Son SH, Hong CM, Jeong JH, Jeong SY, Ahn BC, Lee J.
    Endocr Pract; 2019 Aug; 25(8):787-793. PubMed ID: 31013158
    [Abstract] [Full Text] [Related]

  • 11. Non-FDG-avid primary papillary thyroid carcinoma may not differ from FDG-avid papillary thyroid carcinoma.
    Kim MH, Ko SH, Bae JS, Lee SH, Jung CK, Lim DJ, Baek KH, Kim SH, Lee JM, Kang MI, Cha BY.
    Thyroid; 2013 Nov; 23(11):1452-60. PubMed ID: 23688271
    [Abstract] [Full Text] [Related]

  • 12. F18-fluorodeoxyglucose positron emission tomography in detecting metastatic papillary thyroid carcinoma with elevated human serum thyroglobulin levels but negative I-131 whole body scan.
    Hung MC, Wu HS, Kao CH, Chen WK, Changlai SP.
    Endocr Res; 2003 May; 29(2):169-75. PubMed ID: 12856803
    [Abstract] [Full Text] [Related]

  • 13. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
    Rivera M, Ghossein RA, Schoder H, Gomez D, Larson SM, Tuttle RM.
    Cancer; 2008 Jul 01; 113(1):48-56. PubMed ID: 18484584
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinicopathological characteristics including BRAF V600E mutation status and PET/CT findings in papillary thyroid carcinoma.
    Choi EK, Chong A, Ha JM, Jung CK, O JH, Kim SH.
    Clin Endocrinol (Oxf); 2017 Jul 01; 87(1):73-79. PubMed ID: 28329426
    [Abstract] [Full Text] [Related]

  • 17. Euthyroid status after total thyroidectomy due to functioning lung metastases from a clear cell variant of papillary thyroid carcinoma.
    Lee JI, Chung YJ, Park SJ, Ryu HS, Cho BY.
    Thyroid; 2012 Oct 01; 22(10):1084-7. PubMed ID: 22873179
    [Abstract] [Full Text] [Related]

  • 18. Cervical Lymph Node Fine-Needle Aspiration and Needle-Wash Thyroglobulin Reflex Test for Papillary Thyroid Carcinoma.
    Zhang X, Howell JM, Huang Y.
    Endocr Pathol; 2018 Dec 01; 29(4):346-350. PubMed ID: 30203321
    [Abstract] [Full Text] [Related]

  • 19. RISK FACTORS FOR NONREMISSION AND PROGRESSION-FREE SURVIVAL AFTER I-131 THERAPY IN PATIENTS WITH LUNG METASTASIS FROM DIFFERENTIATED THYROID CANCER: A SINGLE-INSTITUTE, RETROSPECTIVE ANALYSIS IN SOUTHERN CHINA.
    Chen P, Feng HJ, Ouyang W, Wu JQ, Wang J, Sun YG, Xian JL, Huang LH.
    Endocr Pract; 2016 Sep 01; 22(9):1048-56. PubMed ID: 27124694
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.